Skip to content
Screener

Discontinued — last reported Q4 '20

Net margin at other companies

ALN
Alnylam PharmaceuticalsALNY
15.3%+10.7pp
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-672.2%-139pp
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
-13,856.5%-15,058pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-435.2%-469pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,738.4%+1,407pp
uniQure logo
uniQureQURE
-1,350.7%-35.3pp

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$875.52M+219%
Enterprise value$865.48M+237%

Profitability

See full
Operating margin-3,685.8%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Calculated from Design Therapeutics, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Design Therapeutics, Inc.’s 10-K, filed March 10, 2022. Open the filing →

Filed
Mar 10, 2022, 4:17 PM EST
Fiscal year
FY2021
Accession
0000950170-22-003369

FAQ

What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.